Medical University of Vienna
š¦š¹Austria
- Country
- š¦š¹Austria
- Ownership
- Private
- Established
- 1365-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.meduniwien.ac.at
Body Composition Monitoring for Determination of the Fluid Status in Volunteers Undergoing Intravenous Fluid Therapy
Not Applicable
Completed
- Conditions
- Fluid ShiftsBody Fluid Compartments
- Interventions
- Drug: Elo-melĀ® (Fresenius Kabi Austria)Device: Body Composition Monitoring
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 15
- Registration Number
- NCT02296294
- Locations
- š¦š¹
Medical University of Vienna, Vienna, Austria
Blood Flow Regulation in Glaucoma
Completed
- Conditions
- Glaucoma
- Interventions
- Other: Isometric exercise
- First Posted Date
- 2014-11-17
- Last Posted Date
- 2021-09-01
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 120
- Registration Number
- NCT02292381
- Locations
- š¦š¹
Medical University of Vienna, Vienna, Austria
Pilot Trial: Comparison of Flow Patterns
Not Applicable
- Conditions
- Aortic Valve StenosisAortic Valve Insufficiency
- Interventions
- Radiation: Cardiac CT-scan
- First Posted Date
- 2014-11-11
- Last Posted Date
- 2018-03-27
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 20
- Registration Number
- NCT02288871
- Locations
- š¦š¹
Medical University of Vienna, Vienna, Austria
High "on Treatment" Platelet Reactivity in the Intensive Care Unit
Phase 2
- Conditions
- Critical Illness
- Interventions
- First Posted Date
- 2014-11-07
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 200
- Registration Number
- NCT02285751
- Locations
- š¦š¹
General Hospital, Vienna, Austria
A Prospective Randomized Double-Blinded Placebo Controlled, Explorative Phase I Trial to Investigate the Safety and Tolerability of Two Different Doses of Topically Administered APOSECā¢ in Healthy Male Subjects With Artificial Dermal Wounds
Phase 1
Completed
- Conditions
- HealthyArtificial Dermal Wound
- Interventions
- Drug: APOSECā¢ for cutaneous use
- First Posted Date
- 2014-11-06
- Last Posted Date
- 2015-09-28
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 10
- Registration Number
- NCT02284360
- Locations
- š¦š¹
Medical University of Vienna, Department of Clinical Pharmacology, Vienna, Austria
Does Acetylsalicylic Acid Reduce the Mortality of Patients Admitted to an Intensive Care Unit
Phase 3
Terminated
- Conditions
- Critical Illness
- Interventions
- Drug: 0.9% sodium-chloride solutionDrug: Acetylsalicylic acid lysinate
- First Posted Date
- 2014-11-06
- Last Posted Date
- 2019-12-18
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 15
- Registration Number
- NCT02285153
- Locations
- š¦š¹
General Hospital, Vienna, Austria
Impact of Deep Endometriosis Surgery on Bladder Function
- Conditions
- Deep Infiltrating Endometriosis
- First Posted Date
- 2014-09-12
- Last Posted Date
- 2014-09-12
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 50
- Registration Number
- NCT02238678
Effect of Chronic Intranasal Oxytocin Administration on Sexual Function in Pre- and Postmenopausal Women
Phase 2
Completed
- Conditions
- Female Sexual Dysfunction
- Interventions
- Drug: Syntocinon NasalsprayDrug: Placebo Nasalspray
- First Posted Date
- 2014-09-01
- Last Posted Date
- 2014-09-01
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 30
- Registration Number
- NCT02229721
- Locations
- š¦š¹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria, Vienna, Austria
Effect of RetaronĀ® on Oxygen Induced Retinal Vasoconstriction in LPS Induced Inflammatory Model in Humans
Not Applicable
Completed
- Conditions
- Imparied Retinal Vascular ReactivityHealthy Subjects
- Interventions
- Drug: Escherichia coli EndotoxinOther: PlaceboDietary Supplement: RetaronĀ®
- First Posted Date
- 2014-08-20
- Last Posted Date
- 2014-08-20
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 40
- Registration Number
- NCT02221089
- Locations
- š¦š¹
Department of clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Impact of Preterm Single Donor Milk in Very Low Birth Weight Infants
Completed
- Conditions
- Infant, Premature, Diseases
- Interventions
- Other: Preterm Single Donor Milk GroupOther: Control Group
- First Posted Date
- 2014-08-13
- Last Posted Date
- 2014-08-13
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 300
- Registration Number
- NCT02216292
- Locations
- š¦š¹
Medical University of Vienna, Vienna, Austria
Ā© Copyright 2025. All Rights Reserved by MedPath